Hybrigenics SA
ALHYG | PA
Overview
Corporate Details
- ISIN(s):
- FR0004153930
- LEI:
- 9695003KQD0XMJYDX764
- Country:
- France
- Address:
- 850 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
- Website:
- https://www.hybrigenics.com
- Sector:
- Health Care
- Industry:
- Biotechnology
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-30 18:00 |
Earnings Release
RÉSULTATS ANNUELS CONSOLIDÉS 2024
|
French | 290.7 KB | |
| 2024-10-31 18:00 |
Earnings Release
RÉSULTATS SEMESTRIELS 2024
|
French | 187.0 KB | |
| 2024-10-01 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Assemblée générale mixte du 30 septembre 2024 : Approbation des comptes annuels…
|
French | 272.4 KB | |
| 2024-07-18 18:00 |
Capital/Financing Update
ATON FINALISE AVEC SUCCES SA RESTRUCTURATION FINANCIERE
|
French | 283.7 KB | |
| 2024-06-17 18:30 |
General Meeting Notice
ASSEMBLEE GENERALE ORDINAIRE LE 2 JUILLET 2024
|
French | 142.5 KB | |
| 2024-06-07 18:30 |
Capital/Financing Update
ENGAGEMENT DE DISCUSSIONS AVEC LES CREANCIERS EN VUE D'ASSAINIR LA SITUATION FI…
|
French | 148.9 KB | |
| 2024-04-30 18:30 |
Earnings Release
RÉSULTATS ANNUELS 2023 - REPORT DE LA PUBLICATION DU RAPPORT ANNUEL 2023
|
French | 248.9 KB | |
| 2024-03-07 18:00 |
Inside Information Statement
ÉCHELONNEMENT DU REMBOURSEMENT DE L'EMPRUNT OBLIGATAIRE CONVERTIBLE DE 1,5 M EU…
|
French | 240.5 KB | |
| 2024-02-22 18:00 |
Business and Financial Review
2023 : une année de profondes transformations - Situation de trésorerie au 31 d…
|
French | 282.3 KB | |
| 2023-12-22 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Compte-rendu de l'assemblée générale du 21 décembre 2023
|
French | 185.9 KB | |
| 2023-11-17 18:30 |
Inside Information Statement
POINT SUR LA SITUATION DU GROUPE ATON (HYBRIGENICS SA)
|
French | 255.7 KB | |
| 2023-10-31 18:00 |
Earnings Release
RESULTATS SEMESTRIELS 2023
|
French | 269.4 KB | |
| 2023-10-25 18:00 |
Inside Information Statement
ATON (EX-HYBRIGENICS) RENFORCE SES RESSOURCES FINANCIERES EN EMETTANT UN EMPRUN…
|
French | 297.2 KB | |
| 2023-10-11 08:00 |
Inside Information Statement
HYBRIGENICS : Stemcis étend ses horizons à l'international avec l'ouverture d'u…
|
French | 183.5 KB | |
| 2023-09-26 17:45 |
Regulatory News Service
HYBRIGENICS SE REPOSITIONNE SOUS LE NOM D'ATON ET COMMUNIQUE SA STRATÉGIE POUR …
|
French | 1.4 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |